Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study

Blood. 2018 Aug 2;132(5):547-550. doi: 10.1182/blood-2018-03-835413. Epub 2018 Jun 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anemia, Hemolytic, Autoimmune*
  • Bortezomib
  • Humans
  • Metadata
  • Neoplasm Recurrence, Local
  • Prospective Studies
  • Translational Medical Research
  • Workflow

Substances

  • Bortezomib